Related Experiment Video
Updated: Jun 8, 2026
10:05
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
The treatment potential in preventive cardiology
1National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse Street, London, SW3 6LY, UK. d.wood@ic.ac.uk
Atherosclerosis. Supplements
|April 5, 2001
Summary
European guidelines recommend preventing coronary heart disease (CHD) by focusing on lifestyle changes and medication for high-risk patients. Further risk reduction is possible by improving adherence to these prevention strategies.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Established guidelines exist for preventing coronary heart disease (CHD).
- Patients with existing CHD or atherosclerotic disease are at high risk for further events.
- Current clinical practice shows many patients do not meet recommended lifestyle and risk factor goals.
Purpose of the Study:
- To outline the 1998 Joint European Societies' recommendations for CHD prevention in clinical practice.
- To identify priorities for CHD prevention, focusing on high-risk individuals.
- To highlight the potential for improved preventive care through lifestyle and pharmacotherapy.
Main Methods:
- Review of the 1998 Joint European Societies' recommendations.
- Analysis of clinical practice surveys (e.g., EUROASPIRE) to assess goal achievement.
- Identification of key lifestyle and risk factor targets for CHD prevention.
Main Results:
- Top priority: patients with established CHD or atherosclerotic disease.
- Lifestyle goals: smoking cessation, healthy diet, physical activity.
- Risk factor goals: Blood Pressure < 140/90 mmHg, Total Cholesterol < 5.0 mmol/l, LDL-Cholesterol < 3.0 mmol/l.
- Recommended drug therapies: aspirin, beta-blockers, ACE inhibitors, lipid modification, anticoagulants.
- Screening of relatives of patients with premature CHD.
Conclusions:
- Significant potential exists to reduce CHD risk in established cases.
- Improved adherence to lifestyle modifications and pharmacotherapy can enhance preventive care.
- Effective implementation leads to longer life and better quality for patients.
Related Concept Videos
01:30Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...